ASHFORD FLOWERS LTD
Company number 12628622 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
ASHFORD FLOWERS LTD - Analysis Report
Company Number: 12628622
Analysis Date: 2025-07-20 16:06 UTC
Financial Health Assessment of ASHFORD FLOWERS LTD
(as at 31 May 2024)
1. Financial Health Score: C
Explanation:
ASHFORD FLOWERS LTD shows signs of financial stress and weakening liquidity compared to prior years. While still active and solvent, the company’s net assets have declined substantially from £6,280 in 2020 to £1,081 in 2024. The sharp deterioration in cash reserves and increase in long-term creditors suggest constrained operational cash flow and rising obligations. This results in a middling grade, reflecting caution but no immediate insolvency.
2. Key Vital Signs
| Vital Sign | 2024 Value (£) | Interpretation |
|---|---|---|
| Net Assets | 1,081 | Very low equity cushion; reduced from £6,280 in 2020, signaling erosion of financial strength. |
| Current Assets | 11,477 | Includes low cash (£166) and substantial debtors (£11,274); liquidity depends heavily on receivables collection. |
| Current Liabilities | 5,605 | Short-term debts manageable but rising trend of taxation/social security costs within creditors. |
| Net Current Assets | 5,872 | Positive working capital, but down from £12,111 in 2023, showing reduced short-term financial flexibility. |
| Cash at Bank | 166 | Alarmingly low cash reserves, indicating possible cash flow constraints ("weak pulse"). |
| Trade Creditors (Current) | 824 | Significant drop from prior year (£9,021), possibly due to payment of suppliers or restructuring of payables. |
| Long-Term Creditors | 4,791 | Considerable non-current liabilities, reduced from £9,632, implying possible debt repayment or renegotiation. |
| Debtors | 11,274 | High level of receivables; risk of delayed cash inflows if collection is slow. |
3. Diagnosis
Symptoms Analysis:
- The company’s net assets have steadily declined over the past four years, indicating ongoing losses or withdrawals exceeding profits. This erosion is a symptom of financial stress.
- Cash holdings have dropped dramatically from £4,524 in 2020 to just £166 in 2024, which is a critical symptom of strained liquidity — akin to a patient with a weak heartbeat requiring immediate attention.
- Despite healthy net current assets, much of this is tied up in debtors rather than liquid cash, raising concerns about cash conversion cycles and working capital management.
- The increase in taxation and social security creditors within current liabilities points to possible cash flow timing issues or deferred payments, which can stress ongoing operations.
- The company employs only 2 people, indicating a small-scale operation, which may have limited financial resilience.
- No evidence of fixed assets or long-term investments suggests limited collateral or asset backing to support borrowing or operational flexibility.
Overall Diagnosis:
ASHFORD FLOWERS LTD appears to be a small retail business currently experiencing financial strain, particularly in cash management and equity preservation. While not insolvent, the company’s financial "vital signs" show symptoms of distress that could worsen without intervention. The erosion of equity and near depletion of cash reserves are warning signs that the company must address urgently.
4. Recommendations
To improve financial wellness and stabilize the company’s condition:
Improve Cash Flow Management:
- Tighten credit control to reduce debtor days and improve cash collections, converting receivables into cash faster.
- Negotiate payment terms with suppliers and tax authorities to smooth out outflows and avoid penalties.
Increase Cash Reserves:
- Consider short-term financing options if necessary to bolster liquidity buffer and avoid operational disruptions.
- Explore opportunities to increase sales or diversify revenue streams to boost cash inflows.
Cost Control and Expense Monitoring:
- Review operating expenses closely to identify non-essential costs and improve profitability margins.
- Monitor taxation and social security obligations to prevent accumulation of overdue liabilities.
Capital Injection:
- Explore equity injection from shareholders or external investors to restore the equity base and improve net assets.
Strategic Business Review:
- Evaluate business model viability in the current market, considering pricing, product mix, and competitive positioning.
- Investigate opportunities for operational efficiency improvements or partnerships.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.